Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

April 2029 50

  1. Primary completion A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05739383

  2. Primary completion Left Bundle Branch Pacing vs Right Ventricular Pacing on AHRE Burden in Patients With Preserved LVEF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07250529

  3. Study completion Novel Wearable Device for Heart Failure Management Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05642650

  4. Primary completion Novel Wearable Device for Heart Failure Management Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05642650

  5. Study completion The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05618353

  6. Study completion The Solaris DE Sirolimus-Eluting Covered Stent for the Treatment of AV Access Stenosis or Occlusion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06096142

  7. Primary completion Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06246799

  8. Study completion Second Line Endovascular Treatment in Acute DVT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06486181

  9. Study completion Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06571149

  10. Study completion Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06638944

  11. Study completion Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ablation Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06931821

  12. Primary completion PRIMA-HF: Predicting Myocardial Recovery in Heart Failure Using Cardiac Imaging HAI-HF: High Dosing vs. Standard Dosing Adenosine During Myocardial Perfusion in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07243119

  13. Study completion Silicon-based Photon Counting Computed Tomography for Advanced Cardiac Imaging Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07411196

  14. Primary completion Silicon-based Photon Counting Computed Tomography for Advanced Cardiac Imaging Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07411196

  15. Primary completion Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim 3 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07589387

  16. Study completion CS1 Added to Standard of Care Therapy for Pulmonary Arterial Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07761572

  17. Study completion A Trial Assessing the Effectiveness of Evolocumab in Reducing the Plaque Burden in Participants With Subclinical Atheroma Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07803679

  18. Primary completion A Trial Assessing the Effectiveness of Evolocumab in Reducing the Plaque Burden in Participants With Subclinical Atheroma Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07803679

  19. Study completion Intravenous Thrombolysis, Endovascular Treatment, or Bridging Therapy for Medium Vessel Occlusion Stroke Within 24 Hours Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07931807

  20. Primary completion Intravenous Thrombolysis, Endovascular Treatment, or Bridging Therapy for Medium Vessel Occlusion Stroke Within 24 Hours Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07931807

May 2029 27

  1. Study completion Balloon vs. Self Expanding Transcatheter Valve for Degenerated Bioprosthesis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04843072

  2. Study completion DragonFly EU Pivotal Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05927441

  3. Study completion HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07379190

  4. Study completion Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07485062

  5. Primary completion Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07485062

  6. Study completion Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05105633

  7. Study completion Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06217302

  8. Primary completion A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07030101

  9. Study completion DIROXIMEL FUMARATE TO REDUCE PERIHAEMATOMAL OEDEMA IN INTRACEREBRAL HAEMORRHAGE: DOUBLE BLIND RANDOMIZED CLINICAL TRIAL Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07275515

  10. Primary completion DIROXIMEL FUMARATE TO REDUCE PERIHAEMATOMAL OEDEMA IN INTRACEREBRAL HAEMORRHAGE: DOUBLE BLIND RANDOMIZED CLINICAL TRIAL Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07275515

  11. Study completion COMPETE-LM Trial: Drug-Coated Balloon-Enhanced Provisional Stenting in Complex Left Main Disease. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07408674

  12. Primary completion Early Prophylactic Aspirin for Aneurysmal Subarachnoid Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07642427

  13. Study completion ADVA ACE Coronary Stent System in Coronary Artery Disease Patients (ADVANCE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07912541

  14. Study completion Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05874635

  15. Study completion Reperfusion Approach in Predicted In-hospital Delay for Primary PCI in STEMI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07641231

  16. Study completion Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05485961

  17. Primary completion Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05485961

  18. Study completion Esprit BTK Post-Approval Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06656364

  19. Study completion Efficacy of Drug-Eluting Vertebral Artery Stenting Treatment for Atherosclerotic Vertebral Arteries Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05644314

  20. Study completion Transfemoral TAVI With or Without Coronary Angiogram in Patients With Severe Aortic Stenosis (PURE TAVI) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06898086

  21. Study completion Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07016698

  22. Primary completion SUMMIT RISE Study of Acute Ischemic Stroke Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07436156

  23. Study completion Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07668323

  24. Study completion Study of YKYY032 Injection in Adults With Hyperlipoproteinemia (a) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07914660

June 2029 65

  1. Study completion A Danish Pragmatic Randomized Trial of Nutritional Supplements in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06694727

  2. Study completion INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06965504

  3. Primary completion Effects of Vibration-Assisted Physical Activity in Type-2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07350473

  4. Study completion Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe Aortic Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02825134

  5. Study completion Shingrix in Renal Transplant Recipients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04128189

  6. Primary completion Shingrix in Renal Transplant Recipients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04128189

  7. Primary completion Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04298723

  8. Primary completion PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04889872

  9. Study completion Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05995600

  10. Primary completion Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05995600

  11. Study completion RECOMMEND Platform Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06526533

  12. Primary completion Telerehabilitation In The Home After Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06682429

  13. Study completion Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06880770

  14. Study completion Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07227246

  15. Primary completion Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07258290

  16. Primary completion An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07365332

  17. Study completion Use of the Methoxyflurane as Pain-killer in the Prehospital Management of Acute Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07445737

  18. Primary completion Use of the Methoxyflurane as Pain-killer in the Prehospital Management of Acute Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07445737

  19. Study completion SMART-VERAPAF: Self-MAnagement and Random Therapy With VERApamil or Metoprolol in Paroxysmal Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07445789

  20. Primary completion SMART-VERAPAF: Self-MAnagement and Random Therapy With VERApamil or Metoprolol in Paroxysmal Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07445789

  21. Study completion Chocolate Balloon vs Standard Balloon Angioplasty Before Drug-Coated Balloon Treatment for Femoropopliteal Artery Narrowing or Blockage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07471087

  22. Study completion Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and Dementia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07485283

  23. Primary completion Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and Dementia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07485283

  24. Study completion Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07511257

  25. Primary completion Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07511257

  26. Study completion Multi-Site STARgraft (10401) Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07557862

  27. Primary completion Noninvasive CA Monitoring Validation and Autonomic Modulation in Aneurysmal Subarachnoid Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07577739

  28. Study completion Alert-HF: Early Detection and Intervention on Atrial Fibrillation in Heart Failure Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07816458

  29. Primary completion Alert-HF: Early Detection and Intervention on Atrial Fibrillation in Heart Failure Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07816458

  30. Study completion REFINE-CAC Protocol: Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is confirmEd to Improve Coronary Artery Disease Care Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07853716

  31. Primary completion REFINE-CAC Protocol: Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is confirmEd to Improve Coronary Artery Disease Care Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07853716

  32. Study completion Evolut Low Risk trial

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients

  33. Primary completion Neuroprotection in Acute Cerebral Ischemia II Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07552818

  34. Study completion Left Bundle Branch Pacing vs Right Ventricular Pacing on AHRE Burden in Patients With Preserved LVEF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07250529

  35. Study completion Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07430956

  36. Study completion Enhancement of Stroke Rehabilitation With Levodopa Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03735901

  37. Study completion Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04474223

  38. Study completion China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04974151

  39. Primary completion China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04974151

  40. Primary completion Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05051033

  41. Study completion Left vs Left Randomized Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05650658

  42. Primary completion Left vs Left Randomized Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05650658

  43. Study completion Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05774288

  44. Primary completion High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05845424

  45. Study completion Venus-Vitae Pivotal Study Smart-Align Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05991271

  46. Study completion Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06246799

  47. Study completion Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06447701

  48. Study completion Accelerated vs. Standard Continuous Renal Replacement Therapy for Patients With Cardiogenic Shock Undergoing Veno-arterial ExtraCorporeal Membrane Oxygenator Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06696235

  49. Primary completion Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06882772

  50. Study completion LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07288398

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study completion Comparative Clinical Study of Drug-coating Balloon Strategy and Drug-eluting Stent Strategy Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04842838

  2. Study completion Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People With T2 Diabetes Registry record

    Expected 2025-06; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04843527

  3. Primary completion Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People With T2 Diabetes Registry record

    Expected 2025-06; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04843527

  4. Study completion DETERMINE: Detemir vs NPH Registry record

    Expected 2025-06; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05124457

  5. Primary completion DETERMINE: Detemir vs NPH Registry record

    Expected 2025-06; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05124457

  6. Primary completion Effect of Antifibrotic Therapy on Regression of Myocardial Fibrosis After Transcatheter Aortic Valve Implantation (TAVI) in Aortic Stenosis Patients With High Fibrotic Burden Registry record

    Expected 2025-06; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05230901

  7. Primary completion Home-based Remote Monitoring Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05295303

  8. Study completion GEKO Venous Thromboembolism Prevention Study Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05476913

  9. Primary completion A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study) Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05515367

  10. Study completion Statin and Bone Health Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05613400

  11. Study completion Xian-Hua-Cha for Relieving Hyperlipidemia With Obesity Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05632068

  12. Primary completion Evaluating the Safety and Efficacy of the G-stream® Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05780359

  13. Study completion Telemedicine in Atrial Fibrillation: Randomized Clinical Trial in Primary Care (AtrialConnect) Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05893199

  14. Primary completion Stent Implantation Versus Balloon Dilation for Acute Anterior Circulation Tandem Occlusion Registry record

    Expected 2025-06; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05902000

  15. Primary completion De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05903976

  16. Primary completion Efficacy of Oral Acetazolamide in Decongestion in Patients With Heart Failure Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05940220

  17. Study completion Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY) Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06030544

  18. Study completion Future Patient - Telerehabilitation of Patients With Atrial Fibrillation Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06101485

  19. Primary completion Mobile Application for Self-Management of Type 2 Diabetes Mellitus Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06176703

  20. Study completion Effectiveness and Safety of Coronary Scoring Balloon Dilation Catheter in the Pretreatment of Coronary Stenosis Lesions Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06291545

  21. Study completion Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06381947

  22. Primary completion Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06381947

  23. Study completion Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh Registry record

    Expected 2025-06; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06449235

  24. Primary completion Calcium-Phosphorus Regulation Therapy on Heart Valve Disease Registry record

    Expected 2025-06; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06660524

  25. Primary completion Integrated Traditional Chinese Medicine Day Care Program for Metabolic Syndrome Registry record

    Expected 2025-06; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06703788

  26. Primary completion Single Arm, Prospective, Open-label, Multi-center Clinical Investigation for the Demax Guide Wire Registry record

    Expected 2025-06; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06735846

  27. Primary completion EArly Effect of Glucocorticoid on Incidence of Persistent Left BundlE Branch Block (LBBB) Post-TAVR (EAGLE-TAVR Trial) Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06762145

  28. Primary completion Safety & Efficacy of Qurs e Fishar in Mild to Moderate Hypertensive Patients in Pakistan Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06852079

  29. Study start Study of Human Ocular Hemodynamics by Holography Dopple Registry record

    Expected 2025-06; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06989996

  30. Study start Use of PRP in Open Surgery for Type A Aortic Dissection Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07005661

  31. Primary completion EVOLVING AZIMUTH IN MUSA CONTEXT Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07022067

  32. Study start Evaluation of a Novel Intrasaccular Embolization Device for the Treatment of Intracranial Aneurysms Registry record

    Expected 2025-06; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07022249

  33. Study start Comparison of Different Pulsed Field Ablation Catheters in Atrial Fibrillation Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07036965

  34. Study start Post-Market Study of ZENFLEX Pro Stent for Femoropopliteal Artery Lesions Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07049120

  35. Study completion Postoperative Thrombosis Prevention in Patients With CD Registry record

    Expected 2025-07-01; that period ended on 2025-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04486859

  36. Study completion Dapagliflozin Effect in Cognitive Impairment in Stroke Trial Registry record

    Expected 2025-07-01; that period ended on 2025-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05565976

  37. Primary completion Folic Acid Supplementation in Calcific Aortic Valve Disease Registry record

    Expected 2025-07-01; that period ended on 2025-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05861648

  38. Primary completion Effects of Pioglitazone in Calcific Aortic Valve Disease Registry record

    Expected 2025-07-01; that period ended on 2025-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05875675

  39. Study completion Aspirin Treatment for Small Unruptured InTracranial Aneurysms With Ischemic cereBrovascuLar diseasE Registry record

    Expected 2025-07-01; that period ended on 2025-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05907902

  40. Primary completion Aspirin Treatment for Small Unruptured InTracranial Aneurysms With Ischemic cereBrovascuLar diseasE Registry record

    Expected 2025-07-01; that period ended on 2025-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05907902

  41. Primary completion taVNS Paired With Motor Training for Upper-extremity Rehabilitation in Stroke Patients Registry record

    Expected 2025-07-01; that period ended on 2025-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05943431

  42. Primary completion The Effects of CGM and Connected Pen in T2DM Treated With Multiple Daily Insulin Injections Registry record

    Expected 2025-07-01; that period ended on 2025-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06311019

  43. Study start Early Endovascular Repair Versus Surveillance for Women With Small Abdominal Aortic Aneurysm Registry record

    Expected 2025-07-01; that period ended on 2025-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06394271

  44. Study start Remote Ischemic Conditioning for Efficacy in Patients With Aneurysmal Subarachnoid Hemorrhage Registry record

    Expected 2025-07-01; that period ended on 2025-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06711302

  45. Study start DCB for CAD With Type 2 Diabetes Registry record

    Expected 2025-07-01; that period ended on 2025-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07009938

  46. Study start Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease. Registry record

    Expected 2025-07-01; that period ended on 2025-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07025980

  47. Study start Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial Registry record

    Expected 2025-07-01; that period ended on 2025-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07030621

  48. Study start Colchicine for Secondary Prevention After Ischemic Stroke (CHANCE-3 EX) Registry record

    Expected 2025-07-04; that period ended on 2025-07-04.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07035405

  49. Primary completion Safety and Efficacy of the HighLife Transcatherter Mitral Valve Replacement System in Patients With Moderate-severe or Severe Mitral Regurgitation in China Registry record

    Expected 2025-07-06; that period ended on 2025-07-06.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05610566

  50. Study start Effect of Henagliflozin on Renal Outcomes in Non-dialysis Patients With Advanced Chronic Kidney Disease : A Multicenter Prospective, Randomized Controlled Trial(HERO -aCKD) Registry record

    Expected 2025-07-10; that period ended on 2025-07-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07027774

  51. Study completion Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke Registry record

    Expected 2025-07-12; that period ended on 2025-07-12.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06202755

  52. Study completion Cerebroprotective Effect of Melatonin in Stroke Registry record

    Expected 2025-07-14; that period ended on 2025-07-14.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05857046

  53. Primary completion VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization Registry record

    Expected 2025-07-20; that period ended on 2025-07-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06873321

  54. Study completion Investigating the Efficacy of Combining Virtual Reality-Based Mirror Therapy (VRMT) and Transcranial Direct Current Stimulation (tDCS) to Improve Upper Limb Recovery in Patients with Stroke Registry record

    Expected 2025-07-21; that period ended on 2025-07-21.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06764797

  55. Study completion Vascular Inflammation ReDuction and Perivascular Fat Imaging by Computed Tomography Registry record

    Expected 2025-07-22; that period ended on 2025-07-22.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06083337

  56. Primary completion Vascular Inflammation ReDuction and Perivascular Fat Imaging by Computed Tomography Registry record

    Expected 2025-07-22; that period ended on 2025-07-22.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06083337

  57. Primary completion Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction Registry record

    Expected 2025-07-30; that period ended on 2025-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04798430

  58. Study completion VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization Registry record

    Expected 2025-07-30; that period ended on 2025-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06873321

  59. Study completion A Clinical Evaluation of the HYDRA Self Expanding Transcatheter Aortic Valve Registry record

    Expected 2025-07; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02434263

  60. Study completion BGP+ Stent as Bridging Stent in BEVAR Registry record

    Expected 2025-07-31; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03982940

  61. Primary completion Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus Registry record

    Expected 2025-07; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04838392

  62. Study completion Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial). Registry record

    Expected 2025-07; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05122780

  63. Primary completion Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial). Registry record

    Expected 2025-07; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05122780

  64. Study completion Clinical Implications of FKBP5 in Stroke Registry record

    Expected 2025-07; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05198037

  65. Primary completion Clinical Implications of FKBP5 in Stroke Registry record

    Expected 2025-07; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05198037

  66. Primary completion Belgian Study to Assess the Efficacy and Safety of the RESTORER Iliac Stent for Treatment of Aorto-iliac Lesions. Registry record

    Expected 2025-07-31; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05293002

  67. Primary completion Low Dose Prasugrel vs Clopidogrel for Stenting or Flow Diverter for Unruptured Aneurysm Registry record

    Expected 2025-07; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05359224

  68. Study completion Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease Registry record

    Expected 2025-07; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05442203

  69. Primary completion Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease Registry record

    Expected 2025-07; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05442203

  70. Study completion DIAbetes Maximal ACCeleration Registry record

    Expected 2025-07; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05646147

  71. Study completion The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole) Registry record

    Expected 2025-07-31; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05820048

  72. Study completion Pre-operative Antihypertension Strategies-Carotid Artery Stenting Registry record

    Expected 2025-07-31; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05905848

  73. Primary completion Assessment of Efficacy and Safety of Amicomed®, for the Management of Essential Hypertension Registry record

    Expected 2025-07-31; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06091176

  74. Study completion Renoprotective Effects of Dapagliflozin Versus Pentoxiphylline in Chronic Kidney Disease Patients Registry record

    Expected 2025-07; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06421870

  75. Study completion Single Arm, Prospective, Open-label, Multi-center Clinical Investigation for the Demax Guide Wire Registry record

    Expected 2025-07; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06735846

  76. Study completion EArly Effect of Glucocorticoid on Incidence of Persistent Left BundlE Branch Block (LBBB) Post-TAVR (EAGLE-TAVR Trial) Registry record

    Expected 2025-07-31; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06762145

  77. Primary completion Efficacy of Remote Monitoring of Patients With Heart Failure and Reduced Ejection Fraction by Using Caaring® Software Registry record

    Expected 2025-07; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06920160

  78. Study start Single Dose PCSK9 Inhibitor to Improve Cardiovascular Outcomes After PCI: A Pilot Study Registry record

    Expected 2025-07; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07084259

  79. Study start Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Efficacy Comparative Study Registry record

    Expected 2025-07-31; that period ended on 2025-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07088523

  80. Study completion Freestyle Libre and Hospital Admissions in Type 2 Diabetes Registry record

    Expected 2025-08-01; that period ended on 2025-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04997512

  81. Primary completion Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes Registry record

    Expected 2025-08-01; that period ended on 2025-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06439758

  82. Study start Prevention and Treatment for Bruises in Patients With Ischemic Stroke Registry record

    Expected 2025-08-01; that period ended on 2025-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06823999

  83. Primary completion Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes Registry record

    Expected 2025-08-01; that period ended on 2025-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06825182

  84. Study start Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian Section Registry record

    Expected 2025-08-01; that period ended on 2025-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06946589

  85. Primary completion Clinical Safety and Efficacy Testing of a Medical Device Kardi Ai, an ECG Telemetry Monitoring System Registry record

    Expected 2025-08-01; that period ended on 2025-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07018648

  86. Study start Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in Patients With Type 2 Diabetes Registry record

    Expected 2025-08-01; that period ended on 2025-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07046273

  87. Study start Effect of Digital Intervention on Self-management of Hypertensive Patients at High Risk of Stroke Registry record

    Expected 2025-08-01; that period ended on 2025-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07089810

  88. Study start SLGT2i for Neuroprotection in Patients With Acute Ischemic Stroke Registry record

    Expected 2025-08-01; that period ended on 2025-08-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07105917

  89. Study start Y-6 Sublingual Tablets for Patients With Acute Ischemic Stroke Registry record

    Expected 2025-08-05; that period ended on 2025-08-05.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07040085

  90. Study start Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke Due to Large Artery Atherosclerosis Registry record

    Expected 2025-08-10; that period ended on 2025-08-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06775782

  91. Study completion Research on Diagnosis and Prognosis of Myocardial Ischemia Level Using Magnetocardiography Registry record

    Expected 2025-08-14; that period ended on 2025-08-14.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05718206

  92. Primary completion A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial Registry record

    Expected 2025-08-16; that period ended on 2025-08-16.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03947229

  93. Study start To Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent System Registry record

    Expected 2025-08-18; that period ended on 2025-08-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07098195

  94. Study start Epicardial Delivery of XC001 Gene Therapy to Promote Angiogenesis in CAD Patients Undergoing Treatment With CABG Registry record

    Expected 2025-08-27; that period ended on 2025-08-27.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07118449

  95. Primary completion Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke:Longterm Outcome (OPENS-3L) Registry record

    Expected 2025-08-30; that period ended on 2025-08-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05965193

  96. Primary completion Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes Registry record

    Expected 2025-08-30; that period ended on 2025-08-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06339086

  97. Study completion Clinical Safety and Efficacy Testing of a Medical Device Kardi Ai, an ECG Telemetry Monitoring System Registry record

    Expected 2025-08-30; that period ended on 2025-08-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07018648

  98. Study start Clinical Study on the Efficiency of Rapid Arrhythmia Mapping Using EasyStars™ High Density Mapping Catheter Applications Registry record

    Expected 2025-08-30; that period ended on 2025-08-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07079813

  99. Study completion Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia Registry record

    Expected 2025-08; that period ended on 2025-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04603508

  100. Study completion Beta Blocker De-prescription Following Coronary Artery Bypass Graft Surgery (BEEFBURGER Trial). Registry record

    Expected 2025-08-31; that period ended on 2025-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04788186